Caitong International Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Caitong International Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-93,685	Closed	-$3.72M	–	3064
2026 Q1	$3.72M	Buy	93,685 +90,467	+2,811%	+$2.31M	0.69%	29
2025 Q4	$80.5K	Buy	+3,218	New	+$81.5K	0.02%	523
2025 Q2	–	Sell	-3,215	Closed	-$46.2K	–	2076
2025 Q1	$46.2K	Buy	3,215 +3,194	+15,210%	+$52.3K	0.03%	520
2024 Q4	$352	Buy	+21	New	+$348	﹤0.01%	1510

Caitong International Asset Management's CNTA Position: Q2 2026 in Review

Caitong International Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 93,685 shares — an estimated $3.72M sold.

Caitong International Asset Management first reported a position in CNTA in Q4 2024 and held it in 4 quarters. The position peaked at $3.72M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Caitong International Asset Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Caitong International Asset Management sold 93,685 Centessa Pharmaceuticals shares in Q2 2026, an estimated $3.72M.
Caitong International Asset Management first reported a position in Centessa Pharmaceuticals in Q4 2024 and held it in 4 quarters.
Caitong International Asset Management's Centessa Pharmaceuticals position peaked at $3.72M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.